VYNE Therapeutics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
VYNE Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2024.
  • VYNE Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $699K, a 1.55% decline year-over-year.
  • VYNE Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $3.3M, a 0.06% decline year-over-year.
  • VYNE Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2024 was $3.3M, a 0.06% decline from 2023.
  • VYNE Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.31M, a 23.1% decline from 2022.
  • VYNE Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.3M, a 46.8% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.3M -$2K -0.06% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 $3.31M -$992K -23.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 $4.3M -$3.78M -46.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 $8.08M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2019 $6.7M +$6M +857% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-03
2018 $700K -$752K -51.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
2017 $1.45M +$879K +153% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $573K +$508K +782% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $65K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.